ARCHIVED: Update on wearable technology for people living with diabetes
Please note this guidance is now out of date. View the current policy.
Information for people with questions about the availability of new devices that provide remote monitoring of glucose levels.
In March 2022, the National Institute for Health and Care Excellence (NICE) updated the recommendations in its diabetes guidance in relation to glucose monitoring.
The CCG is aware of this updated guidance, and people with diabetes should be assured that work with local diabetes specialist colleagues, as well as other local stakeholders, to implement this updated guidance is ongoing.
At this current time, colleagues are exploring how to maximise the benefits of this new technology, while continuing to prioritise patients with the greatest clinical need, and allowing all people with diabetes access to the best possible treatment for their clinical circumstances.
People with diabetes are kindly asked to remain patient while this process is completed, as further details will be released in due course.
The updated guidance relates to continuous glucose monitoring which is usually managed via the local specialist diabetes service:
- Type 1 diabetes in adults: https://www.nice.org.uk/guidance/ng17/chapter/Recommendations#continuous-glucose-monitoring
- Type 1 and Type 2 diabetes in children and young people: https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#continuous-glucose-monitoring
- Type 2 diabetes in adults: https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#continuous-glucose-monitoring